Publications & Presentations

science driven,
patient focused.

Our platform, which combines oncRNA technology with AI, provides actionable insights into cancer biology.

ESMO 2024

Predicting tumor ER and HER2 status using a cell-free RNA liquid biopsy assay

Sep 2024

ASCO 2024

Harnessing cell-free orphan non-coding RNAs as a predictive measure of long-term survival in neoadjuvant breast cancer therapy

Jun 2024

ASCO 2024

Effect of breast tissue density on cell-free orphan non-coding RNAs secreted by breast cancers

Jun 2024

AACR 2024

Orphan noncoding RNA (oncRNA) liquid biopsy assay is prognostic for survival in patients with triple-negative breast cancer (TNBC) and residual disease

Apr 2024

AACR 2024

Beyond detection: AI-based classification of breast cancer invasiveness using cell-free orphan non-coding RNAs

Apr 2024

SABCS 2023

Cell-free orphan noncoding RNAs and AI enable early detection of invasive breast cancer and ductal carcinoma in situ

Dec 2023

WCLC 2023

AI-Based Early Detection and Subtyping of Non-Small Cell Lung Cancer from Blood Samples Using Orphan Non-Coding RNAs

Sep 2023

ASCO 2023

Detection of early-stage cancers using circulating orphan non-coding RNAs in blood

Jun 2023

BOG 2023

Transcriptome-wide co-expression of small non-coding RNAs and genes in cancer

May 2023

AACR 2023

Blood-based Early Detection of Non-small cell Lung Cancer using Orphan Noncoding RNAs

Apr 2023

SABCS 2022

Early Stage Breast Cancer Detection using Orphan Noncoding RNAs

Dec 2022

ESMO 2022

Serum-Based Colorectal Cancer Detection using OncRNAs

Sep 2022

AACR 2022

Discovery and Validation of Orphan Noncoding RNA Profiles across Multiple Cancers in TCGA and Two Independent Cohorts

Apr 2022

SABCS 2021

Tumor-Released Circulating Orphan Noncoding RNAs Reflect Treatment Response and Survival in Breast Cancer

Dec 2021

NATURE MEDICINE

Cancer Cells Exploit an Orphan RNA to Drive Metastatic Progression

Nov 2018

Keep Reading

No further publications found.